Capstan Therapeutics (capstantx.com): 3 changes recorded in its website history since November 2021.
The site blocks automated visits or asks crawlers to stay out (robots.txt), so it is not checked live; changes are dated from Internet Archive copies when available. Last tried 6 November 2026.
Recorded changes
Newest observations first. Each interval bounds when the website changed; it is not an exact event date.
HeadlineBetween and
BeforeDedicated to advancing targeted in vivo cell engineering
AfterMultiplying the possibilities for patients
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
OVH accompagne votre évolution grâce au meilleur des infrastructures web: hébergement, nom de domaine, serveur dédié, CDN, Cloud, Big Data,...
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2024 – July 2024 · 2 captures · latest observed messagingMultiplying the possibilities™
Capstan’s mission is to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA-based therapies.
4 January 2024 · Multiplying the possibilities for patientsarchived page
13 July 2024 · Multiplying the possibilities™archived page
September 2022 – September 2023 · 3 capturesDedicated to advancing targeted in vivo cell engineering
Our core platform technology pertains to proprietary targeted lipid nanoparticles (tLNPs) that are composed of LNPs conjugated with a recombinant protein binder, such as a monoclonal antibody, and are